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Abstract 
A novel mutant mouse called X-linked pre- and neonatal anemia (gene symbol, Xpna) 
results in a transient, neonatal anemia which is resolved by 3 weeks of age in Xpna females. 
Adult Xpna females exhibit hypoplastic bone marrow with red cell aplasia and splenomegaly 
showing extramedullary erythropoiesis and megakaryocytosis. We identified a splicing defect 
derived from a single nucleotide change 5 base pairs downstream of Exon 1 in Gata1. The Xpna 
Gata1 gene produces a transcript, which includes alternative Exon 1Eb/c, known not to induce 
erythropoiesis. X-chromosome inactivation leads to two populations of hematopoietic cells in 
Xpna females, one of which expresses Xpna Gata1 mRNA. An X-chromosome-associated 
erythroid genetic marker (Pgk1, phosphoglycerate kinase-1) indicates reticulocytes are derived 
from erythropoietic cells expressing the Xpna Gata1 transcript. These data strongly suggest 
compensatory gene expression allowing for the generation of erythrocytes despite the lack of 
GATA-1 production. The Xpna mouse could, therefore, lead to the identification of novel 
erythropoietic factors. 
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Introduction 
Background 
GATA-1 is an essential transcription factor that regulates erythroid differentiation by 
targeting specific genes.
1,2
 The Gata1 gene is composed of multiple untranslated first exons and 
five other common exons.
3
 Three functional domains have been described for the GATA-1 
protein: an N-terminal domain reported to act as a transcriptional activation domain and two zinc 
finger domains, one for binding to DNA and another to stabilize DNA binding.
4
 GATA1 
recognizes the GATA consensus motif, (T/A)GATA(A/G)
5
, and is known to interact with many 
transcribing factors such as FOG-1, LMO2, KLF1, TAL-1 and PU.1.
1,6-13
 
Gene ablation studies of Gata1 in mice revealed its essential role in erythroid cell 
development.
14-16
 Embryos lacking Gata1 die at approximately embryonic day 11.5 due to 
arrested maturation of primitive erythroid cells.
14
 Heterozygous Gata1 knockout females survive 
after experiencing a transient, neonatal anemia.
14
  
Various strategies for gene targeting of Gata1 in mice have generated different 
hematological phenotypes. Mouse Gata1 mutations with inducible knockouts of either Exon 1E 
(the erythroid first exon) alone or Exons 2 through 6, using the cre-lox system, provided insight 
on the role of the different coding regions of Gata1.
3,16
 Induction of floxed deletion of Exon 1E, 
which contains the 5’ untranslated region (UTR) of the Gata1 mRNA, at 3 to 4 weeks of life and 
resulted in dramatic splenomegaly and severe anemia.
3
 In this inducible mutant, an alternative 
Exon (1Eb/c) is utilized in lieu of Exon 1E, resulting in a complete loss of expression of GATA-
1 in the enlarged spleens. The anemia resulting from the inducible knockout persists in these 
mice, suggesting that Exon 1E is important for GATA-1 expression in hematopoietic lineages. 
Alternatively, induction of a Gata1 knockout, including floxed Exon 2 through 6 at 8 to 10 
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weeks, leads to anemia, thrombocytopenia, and decreased spleen weight.
16
 The hematological 
phenotype of these mice was consistent with the loss of GATA-1 expression. 
 Study Objective 
Our objective in this study is to characterize a unique mouse model known as X-linked 
pre- and neonatal anemia (gene symbol, Xpna), which experiences a transient, neonatal anemia. 
The Xpna female mouse displays a severe anemia at birth that gradually regresses and 
completely resolves at approximately 3 weeks of age. We identified the mutation associated with 
Xpna mice as a single base pair mutation in intron 1 of the Gata1 gene. This mutation results in a 
splicing error leading to the expression of a Gata1 transcript that utilizes Exon 1Eb/c as an 
alternative first exon. We hypothesize the recovery from anemia in Xpna mice is due to an 
alternative compensatory mechanism allowing for progression of erythropoiesis. 
Materials and Methods 
Mice 
The Xpna mutant was originally generated by N-ethyl-N-nitrosurea (enu) mutagenesis on 
the C3H101H strain (http://www.informatics.jax.org/reference/J:169366). C3H101H-Xpna/+ 
(Harwell stock number FESA:000520) was a gift from Bruce Cattanach at the Medical Research 
Council Harwell (Oxfordshire, England). We transferred the Xpna mutation to the C3H/HeJ 
strain by repeated matings of Xpna/+ females to C3H/HeJ male mice (obtained from The Jackson 
Laboratory, stock number 000659) for several generations to produce a congenic line. All mice 
were maintained at the University of Missouri-Kansas City (UMKC) Lab Animal Research 
Center with animal usage guidelines and procedures approved by the UMKC Institutional 
Animal Care and Use Committee.  
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Genotyping 
Genomic DNA was extracted from mouse tissue using the Qiagen DNeasy Blood and 
Tissue kit (Qiagen, Valencia, CA) as described previously.
17,18
 The Xpna mutation was detected 
by PCR amplification followed by DNA sequence analysis using primers derived from 
sequences flanking Exon 1 (Table 1). The PCR product was purified with a GE Illustra Spin 
column (VWR, Brisbane, CA) and sequenced at the University of Kansas Medical Center 
Biotechnology Support Facility (Kansas City, KS) using an ABI 377 automated sequencer 
(Applied Biosystems, Foster City, CA).       
 
Genotyping PCR   
 Name Direction Sequence 
 
Xpna Gata1 
F GGAGGAAAGAGGAGGGAGAA 
 R CCGTTTTAGGGGCAACCTAT 
Table 1: Primers used for Xpna genotyping 
Hematology   
Peripheral blood samples were obtained in hematocrit tubes from neonatal C3H/HeJ-
Xpna/+ female pups and normal female littermates.  Red blood cells were counted with a Coulter 
Counter (Model Z1; Miami, FL).  Hematocrit percentage was assessed using an Adams 
Hematocrit Reader (Becton, Dickinson and Company, Parsippany, NJ). Hemoglobin 
concentration of the red cells lysed in Drabkin’s solution (Total Hemoglobin Kit, Sigma 
Diagnostics, St. Louis, MO) was measured in a Perkin-Elmer Lambda 40 spectrophotometer 
(Norwalk, CT) at a wavelength of 530 nm.   
Histology   
Necropsy, histology and pathology analysis of tissues from Xpna mice and wild type 
littermates at 3 months and 6 months of age was completed by IDEXX Laboratories (Columbia, 
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MO). Preparation and analysis of bone marrow smears with Wright’s-Giemsa stain were 
completed using techniques as described previously.
19
 Spleen and liver samples were fixed, 
sectioned, and stained with hematoxylin and eosin. 
Genetic Mapping   
To determine the relative chromosomal location of the Xpna mutation, C3H/HeJ-Xpna/+ 
female mice were mated to the CAST/Ei strain (from The Jackson Laboratory, JAX stock 
number 000664).  A backcross of the (C3H/HeJ X CAST/Ei) F1-Xpna/+ female progeny 
(identified by pallor, low hematocrit and/or Gata1 DNA sequencing of the mutation in intron 1) 
to C3H/HeJ-wild type male mice was used to generate Xpna/+ and +/+ offspring. Female mice 
were the only animals analyzed since Xpna males are never born.  The Xpna/+ mice were scored 
and genomic DNA was extracted from spleens of the backcross mice using the Super Quik Gene 
DNA extraction kit (Analytical Genetic Testing Center, Denver CO).  These DNA samples were 
genotyped with primer pairs (Research Genetics, Huntsville, AL) for a series of simple sequence 
length polymorphisms (CA repeats) as previously described.
20
 A total of 13 genetic markers 
including 12 dinucleotide CA-repeat microsatellite markers and a novel CA repeat identified in 
GenBank (NT 000086) at position nt4858 in the genomic sequence of Glod5 (glyoxalase domain 
containing 5).  
Mutation Analysis  
Genomic DNAs for mouse strains were obtained from The Jackson Laboratory and the 
101H mouse strain sample for DNA extraction was a gift from the Medical Research Council 
Harwell. Genomic PCR was performed using primers derived from flanking sequence 50 bp 
upstream and downstream of the 6 exons in Gata1 using the Fail Safe PCR kit (Epicentre 
Technologies, Madison, WI). The primers were chosen using the Primer 3 program 
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(frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) from the sequence of Gata1 (GenBank 
Accession NC_000086). Analytical gels were 3% GenePure 3:1 agarose (ISCB, Kaysville, UT). 
PCR products were isolated using CENTRI-SEP Spin Columns (Princeton Separations Inc., 
Adelphia, NJ) prior to sequencing by the KU Medical Center Biotechnology Support Facility. 
Splice Site Analysis 
To analyze the status of splice site donors, a perl script was written to extract 189,185 
donor sites and 189,092 acceptor sites from the annotated mouse genome. A pseudo-Gibbs motif 
sampler was run to build the 10-mer donor motif model, and draw a motif logo using BiLogo 
Plotter (BiLogo Plotter. http://bipad.cmh.edu/bilogo.html).21 Scoring of a potential donor 
binding site was performed as previously described.
22
   
RNA Extraction 
RNA extraction from reticulocytes, liver, spleen, fetal liver, and whole embryos was 
performed using the RNeasy Midi Kit (Qiagen, Valencia, CA). RNA from peripheral blood 
reticulocytes were obtained from phenylhydrazine-treated mice prepared as previously 
described.
23
  
5’-RACE PCR and Cloning 
A 5’-RACE System for Rapid Amplification of cDNA Ends kit (Invitrogen, Carlsbad, 
CA) was used according to manufacturer’s instruction using primers described in Table 2. A 
dilution of the RACE PCR product was used as the template for nested amplification using a 
primer that was modified to include EcoR1 recognition sites. This PCR product was purified 
with GE Illustra Spin columns (VWR, Brisbane, CA), cut with EcoR1, and re-purified with the 
columns. The cut DNA was ligated into pBlueScript plasmid (Agilent, La Jolla, CA) using T4 
DNA Ligase (Promega, Madison, WI) and used to transform competent DH5α bacterial cells 
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(Invitrogen, Carlsbad, CA). Plasmid DNA was extracted using the CTAB method.
24
 Positive 
clones were sequenced at the University of Kansas Medical Center Biotechnology Support 
Facility. 
    
5’-RACE-PCR   
 Name Direction Sequence 
 1
st
 Step  R GCTCTTCCCTTCCTGGTCTT 
 2
nd
 Step  R CAGGAATTCCCTCCATACTG 
 3
rd
 Step  R GTAGTAGGCCAGTGCTGATG 
Table 2: Primers used for 5’-RACE-PCR 
RT-PCR 
Gata1 mRNA expression was analyzed by RT-PCR amplification using the SuperScript 
One-Step RT-PCR System for Long Templates (Invitrogen, Carlsbad, CA) using primers derived 
from the cDNA sequence for detection of Gata1 mRNA as described in supplemental Table 3. 
Pgk1 RT-PCR, using reticulocyte RNA as a template, was performed with primers chosen from 
the sequence of Pgk1 (GenBank Accession NT_039711; Table 1).  Pgk1 RT-PCR products were 
purified with GE Illustra Spin columns (VWR, Brisbane, CA) and sequenced at the University of 
Kansas Medical Center Biotechnology Support Facility. 
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RT-PCR   
 Name Direction Sequence 
 
Gata1 Exon 1-3 
F AATCCTCTGCATCAACAAGC 
 R CATAGGCCCAGCTAGCATAA 
 
Gata1 Exon 2-3 
F CTGGTGTCCTCACCATCAGA 
 R CCGTCTTCAAGGTGTCCAAG 
 
Gata1 Exon 1E-3 
F ACTCGTCATACCACTAAGGTGGCTG 
 R CACAGTTGAGGCAGGGTAGAG 
 
Gata1 Exon 1Eb/c-3 
F GAAGTTGGGGAGCACAGAAG 
 R GCTCTTCCCTTCCTGGTCTT 
 
Pgk1 
F CACGGTGTTGCCAAAATGT 
 R GAAAGCGGAGGTTTTCCAG 
Table 3: Primers used for RT-PCR 
Real-time Quantitative RT-PCR (qRT-PCR) 
cDNA was synthesized using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). 
qPCR analysis was performed with SYBR Green dye using MiniOpticon or CFX96 instruments 
(Bio-Rad, Hercules, CA). Expression of embryonic and adult β-globin was calculated using the 
relative quantification method, as previously described (Table 4).
25,26
 qRT-PCR was also 
performed for Gata1, Gata1 Exon 1E, Gata1 Exon 1Eb/c, Gata2 and Gapdh (glyceraldehyde 
phosphate dehydrogenase) mRNAs (Table 4). Triplicate data sets were generated and results 
were normalized to murine Gapdh or α-globin genes (internal controls) for the expression data.  
Data is shown as the mean ± the standard deviation of the mean.  The Student’s t-test was used to 
determine statistical significance at P < 0.05 and P < 0.01. 
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qRT-PCR   
 Name Direction Sequence 
 
Total Gata1 
F CAGAACCGGCCTCTCATCC 
 R TAGTGCATTGGGTGCCTGC 
 
Gata1 IE 
F ACTCGTCATACCACTAAGGTGGCTG 
 R GCCCCTAGACCAGGAAAATC 
 
Gata1 IEb/c 
F GATAGGGATGAAGTTGGGGAGCAC 
 R GCCCCTAGACCAGGAAAATC 
 
Gata2 
F CACCCCGCCGTATTGAATG 
 R CCTGCGAGTCGAGATGGTTG 
 
Gapdh 
F AGGTTGTCTCCTGCGACTTCA 
 R CCAGGAAATGAGCTTGACAAAG 
 
Hprt 
F GCTGGTGAAAAGGACCTCT 
 R CACAGGACTAGAACACCTGC 
 
α-globin 
F GATTCTGACAGACTCAGGAAGAAAC 
 R CCTTTCCAGGGCTTCAGCTCCATAT 
 
Ey 
F CAAGCTACATGTGGATCCTGAGAA 
 R TGCCGAAGTGACTAGCCAAA 
 
βhl 
F AGGCAGCTATCACAAGCATCTG 
 R AACTTGTCAAAGAATCTCTGAGTCCAT 
 
βmaj+βmin 
F GTGAGCTCCACTGTGACAAGCT 
 R GGTGGCCCAGCACAATCACGATC 
Table 4: Primers used for qRT-PCR 
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Results  
Inheritance of Xpna Locus 
Xpna mutant pups are anemic at birth and scored by the observation of pallor as seen in 
Figure 1. The inheritance pattern is that of an X-linked dominant mutation since only Xpna/+ 
females are observed (0 pale male pups out of 129 pale pups born) and mating Xpna females 
with wild type males results in 38% of the offspring exhibiting the anemia phenotype at birth (29 
pale pups out of a total of 77 littermates). Male Xpna embryos have been noted to die in utero 
during mid-gestation at embryonic age 10.5 days (personal communication, e-mail, Bruce 
Cattanach, Medical Research Council Harwell).  
 
Figure 1: Phenotype of anemic Xpna pup; A normal pup is pictured on the right and compared 
to an anemic Xpna/+ pup shown on the left with skin pallor. 
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Hematological Presentation 
Blood samples from 2-day old Xpna mice compared to +/+ female littermates showed 
marked disturbances in red blood cell parameters (Table 5).  Xpna pups showed a significant 
reduction in red blood cell number, hematocrit, and hemoglobin. In contrast, blood samples from 
3-week old Xpna mice showed that the severe, neonatal anemia is resolved establishing that the 
Xpna mutation results in a transient, neonatal anemia. There is also a five-fold increase in 
nucleated red blood cells in the peripheral circulation of Xpna pups which is resolved in adult 
Xpna mice (data not shown). Despite the resolution of the severe anemia, adult Xpna females 
show marked splenomegaly with an average increase in spleen weight of 25% in 3 week old 
mice to an increase of over 200% in 7 month old mice compared to wild type littermates. Adult 
Xpna females also have mild to moderate thrombocytopenia when compared to wild type 
littermates (386±112 x10
3
/µL compared to 738±144 x10
3
/µL; p<0.01). 
Genotype RBC # 
(x10
12
/L) 
Hct (%) Hb (g/L) MCV (fl)  
 
2 day old Xpna/+ 
 
1.48  0.23* 
 
0.18  0.04* 
 
67  11* 
 
124 ± 37       
 
2 day old +/ + 3.46  0.35 0.44  0.05 137  22 126 ± 10  
 
3-week old Xpna/+ 
 
4.91  0.48 
 
0.39  0.05 
 
117  13 
 
79  7       
 
3-week old +/ + 4.52  0.46 0.41  0.03 120  17 77  9         
      
 
Table 5:  Hematologic Data of 2 day old and 3 week old Xpna and Wild-type Mice; Data are 
mean ± standard deviation of the mean.  Hgb indicates hemoglobin; Hct, Hematocrit; RBC #, 
Red Blood Cell Number. *:Mean value for Xpna/+ mice is significantly different from +/+ 
littermates by t-test at P< 0.001, n=8.  
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Spleen, Liver, and Bone Marrow Histology 
Spleen, liver, and bone marrow samples were examined microscopically from adult Xpna 
and +/+ littermates to evaluate for hematological defects.  The bone marrow smears of adult 
Xpna females showed predominantly hypoplastic bone marrow with red cell aplasia (Figure 2A). 
Bone marrow aspirate smears of Xpna mice showed varying results diverging from no cytologic 
abnormalities to marked erythroid hypoplasia. Spleens from Xpna mice showed marked 
megakaryocytosis and mild to moderate hematopoiesis consistently compared to their wild type 
littermates which showed no megakaryocytosis and zero to mild hematopoiesis (Figure 2B). The 
histology of Xpna liver samples showed no difference compared +/+ littermates.   
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Figure 2: Histology of Xpna mice; A) Histological appearance of adult Xpna bone 
marrow smear stained with Wright’s-Giemsa stain consistent with marked erythroid hypoplasia 
to pure red cell aplasia. Original magnification x 50. B) Histological appearance of adult Xpna 
spleen stained with hematoxylin and eosin showing mild hematopoiesis and marked 
megakaryocystosis of the red pulp. Scale bar corresponds to 100 µm. 
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Genetic Mapping  
Chromosomal localization of the Xpna gene was determined by backcross analysis. 
Exactly 76 backcross mice were genotyped and scored for polymorphic microsatellite genetic 
markers (dinucleotide repeats) between C3H101H and CAST/Ei.  The results of the mapping 
study indicated that the Xpna locus was located on the X chromosome with close linkage to 
DXMit26 and Glod5, which lies in very close proximity to Gata1 (www.informatics.jax.org).  
The similar location of Xpna and Gata1, along with the resemblance in hematology data between 
Xpna anemia mutant mice and Gata1 knockout mice, led us to predict that Gata1 was the most 
likely gene candidate for the mutation at the Xpna locus.
14
   
Mutation Analysis 
Comparison of the sequences of the 6 exons of Gata1 between Xpna mice and that of +/+ 
littermates indicates no change in the coding sequence of Gata1. However, there was single 
nucleotide change seen 5 base pairs downstream of Exon 1E (G to A transition) only seen in 
mice carrying the Xpna locus (Figure 3). To verify that this SNP was unique to Xpna, we 
sequenced this region from 21 different inbred mouse strains including the founder strain for 
Xpna mice (C3H101H), 4 other sublines of  the C3H strain (C3H/HeJ,  C3HeB/FeJ, C3H/HeSnJ, 
C3H/HeOuJ) and the 101H parental strain. Analysis of the Gata1 nucleotide sequence in these 
different strains demonstrates that mutation is found only in Xpna mice.  
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Figure 3: Single nucleotide change in Xpna mutation; the chromatogram shows the 
single nucleotide change (G to A transition; indicated by the blue arrow) that is present 5 base 
pairs downstream of Exon 1E in the Gata1 gene of Xpna mice. The black bar indicates the 
division between Exon 1E on the left and intron 1on the right. 
Due to its close proximity to the splicing donor site of exon 1, it was decided to perform 
an analysis of the donor splice site in Xpna mice compared to wild type sequence. A 10-mer 
donor motif was built to generate a consensus sequence AGGTAAG for donor splice signaling. 
The donor sequence model was used to scan both normal and mutant sequence and indicated the 
mutated nucleotide (G->A) has a high impact on the splicing (Figure 4). The normal donor site 
has the highest information content, indicating the correct binding place. However, the mutated 
donor decreases information by nearly 2-fold. The relevant binding energy is significantly 
reduced that may allow its nearby sites to be putative donor sites, causing potential abnormal 
splicing.  
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Figure 4: Xpna Splice Site analysis; the graph shows a decrease in splice site potential, 
represented by a decrease in information content, due to the single nucleotide change identified 
in the Xpna Gata1 allele . 
In order to determine if Exon 1E is skipped due to abnormal splicing, RT-PCR of fetal 
liver RNA from Xpna/+ female, Xpna male (identified by Y genomic PCR and Gata1 
sequencing), wild type male and female embryos was performed. The results showed that Exon 
1E to 3 yielded an appropriate amplicon in all cases except for male Xpna embryos whereas 
products for exon 2 to 3 were seen in all cases including Xpna males. This suggested that Exon 
1E is not included in the final Gata1 transcript generated by the Xpna locus. 
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5’-RACE PCR 
In order to determine what was present at the 5’ end of the Xpna Gata1 mRNA, 5’-RACE 
PCR was completed using 2 day old liver samples from Xpna and +/+ female mice. As shown in 
Figure 5, the 5’-RACE PCR generated an expected wild type product of 323 bp in Xpna and wild 
type mice. However, a slower migrating and larger size amplicon (425 bp) was detected only in 
Xpna samples. Sequence analysis in indicates the wild type band sequence was consistent for 
both Exon 1E and Exon 2 while a novel DNA sequence upstream of Exon 2 was identified in the 
Xpna-specific band. A BLAST search with the sequence revealed that the upstream sequence 
seen in Xpna-specific band is Exon 1Eb/c. Therefore, the result of the Xpna mutation (G to A 
transition) is a splicing mutation in which Exon 1E is not utilized but instead the alternative Exon 
1Eb/c is utilized. The significance of this finding is that Gata1 mRNA transcripts containing 
Exon 1Eb/c have been previously reported to be unable to produce full-length GATA1 protein in 
vivo, possibly due to inefficient translation, resulting in impaired eyrthropoiesis.
3,27 
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Figure 5: 5’-RACE PCR; 5’-RACE analysis of Gata1 mRNA shows the presence of an 
Xpna specific transcript that is 425 bp in size. This band is larger and slower migrating than the 
wild type Gata1 band which is 323 bp in size. 
Absence of Clonal Selection 
A hypothesis was generated to explain the transitional nature of the Xpna anemia in 
which in vivo selection of progenitor cells with an active normal allele is responsible for the 
recovery from the severe neonatal anemia in Xpna females. In order to test the hypothesis we 
identified an X chromosome, red blood cell genetic marker which differs between C3H101H 
Xpna/+ mice and a polymorphic strain CAST/Ei (C>T at position 292 in exon 3 coding region of 
Pgk1 mRNA; rs29095411 SNP at position 106194380nt on the mouse X chromosome). These 
mice were mated to generate (C3H101H X CAST/Ei)F1 Xpna/+ and +/+ female mice carrying a 
X chromosome of C3H101H origin and a X chromosome from the CAST/Ei strain. 
Reticulocytosis was induced and reticulocyte RNA was isolated from peripheral blood for RT-
PCR analysis. Sequencing of the Pgk1 amplicons was utilized to ascertain if clonal selection of 
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erythroid cells with an active CAST/Ei-derived X chromosome was observed in Xpna mice. 
Sequencing analysis from 3 (C3H101H X CAST/Ei)F1 wild type +/+ females and 3 (C3H101H 
X CAST/Ei)F1 Xpna/+ females revealed an identical pattern of expression for both forms of 
Pgk1 mRNA. This indicates the absence of clonal selection in Xpna mice and strongly suggests 
that red blood cells are produced from progenitor cells that can only express the Xpna Gata1 
mutant.  
RT-PCR Analysis  
RT-PCR and qRT-PCR analysis was utilized to evaluate the expression of Gata1 Exon 
1E and Exon 1Eb/c in Xpna mice. This was completed using RNA extractions from day E16 
fetal liver, 2 day-old liver and adult spleen. RT-PCR analysis as shown in Figure 6A and Figure 
6B confirms that  Gata1 mRNA containing Exon 1Eb/c is only expressed in the fetal and 2 day-
old liver of Xpna mice, whereas transcripts containing Exon 1E are expressed in both Xpna and 
wild type mice. qRT-PCR analysis revealed that E16 fetal Xpna liver  had 1.4 fold increase in 
total Gata1 mRNA levels, a 0.45 fold decrease in Gata1 Exon 1E mRNA levels and a 5.5 fold 
increase in Gata1 Exon 1Eb/c mRNA levels (Figure 7A). 2 day-old Xpna liver was found to 
have a 5 fold increase in total Gata1 mRNA levels, a 1.8 fold increase in Gata1 Exon 1E mRNA 
levels and a 65 fold increase in Gata1 Exon 1Eb/c mRNA levels (Figure 7B). Adult Xpna spleen 
was found to have a 4.3 fold increase in total Gata1 mRNA levels, a 1.5 fold increase in Gata1 
Exon 1E mRNA levels and a 146 fold increase in Gata1 Exon 1Eb/c mRNA levels (Figure 7C). 
The high levels of Gata1 Exon 1Eb/c expression further suggests that clonal selection is not 
occurring and supports our hypothesis that red blood cells are being produced from progenitor 
cells that express the Xpna Gata1 mutant.  
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Figure 6: RT-PCR; analysis of Gata1 mRNA from E16 fetal liver and 2 day-old liver 
confirms that Gata1 Exon 1Eb/c is only expressed in Xpna, whereas Gata1 Exon 1E is expressed 
in wild type and Xpna/+ mice. 
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Figure 7: Expression of Gata1 in Xpna and wild type mice; A) expression of total 
Gata1 mRNA  and Gata1 Exon 1Eb/c is significantly elevated and Gata1 Exon 1E mRNA is 
significantly reduced in E16 Xpna fetal liver (n=4). B)  expression of total Gata1 mRNA is 
significantly increased between 2 Day-old wild type and Xpna liver (n=6). C) expression of 
Gata1 mRNA is not significantly different between adult wild type and Xpna spleen (n=4).  
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To understand if known genes represent the compensatory network allowing progenitor 
cells expressing the Xpna Gata1 mutation to generate red blood cells, we examined the 
expression by qRT-PCR of mouse hemoglobins mRNA. In fetal liver, 2 day-old liver and adult 
Xpna spleen, there was no detection of changes in hemoglobin mRNA expression in comparison 
to wild type littermates showing that a reversion to primitive erythropoiesis instead of definitive 
erythropoiesis in these mutant mice is not the compensatory mechanism for their recovery (data 
not shown). Expression of Gata2 mRNA was found to be significantly elevated in Xpna mice at 
all three age points when compared to wild type littermates. There was a 3.2 fold increase in 
mRNA levels in fetal liver, a 4.6 fold increase in mRNA levels in 2 day-old liver, and a 12.5 fold 
increase in mRNA levels in adult spleen (Figure 8). Elevated expression of Gata2 mRNA was 
expected in Xpna mice due to the presence of megakaryocytosis. 
 
Figure 8: Expression of Gata2 in Xpna and wild type mice; expression of Gata2 
mRNA is significantly increased in E16 fetal liver, 2 day-old liver, and adult Xpna spleen 
compared to wild type mice. 
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Discussion 
In this study we have characterized and identified the Xpna hereditary anemia mutation. 
We found by positional cloning that the Xpna locus mapped near the Gata1 gene on the X 
chromosome. Furthermore, similarities between the Xpna hematological phenotype and that of 
mice heterozygous for the GATA-1-Null allele, which are anemic at birth and recover during the 
neonatal period, lead us to predict that Xpna was a Gata1 mutation. We identified a SNP in the 
intron 1 region of the Gata1 gene in Xpna mice, which was predicted to alter mRNA splicing. 
This was confirmed with 5’-RACE PCR, in which we identified that the Xpna mutation results in 
the utilization of the alternative first exon, Exon 1E b/c, in the mRNA transcript instead of Exon 
1E. The anemia that is a result of the splicing error is consistent with a previous study in male 
mice with a Gata1 Exon 1E knockout allele (Gata1
IECKO/Y
), in which the Gata1 transcript 
containing Exon 1Eb/c was shown to be unable to produce a full length GATA1 protein 
therefore impairing erythropoiesis.
3 
 We set out in this study to identify possible mechanisms in which the Xpna mice recover 
from anemia during the neonatal period. The recovery from anemia seen in the heterozygous 
GATA-1-Null mouse, which also has transitional neonatal anemia, has been hypothesized to be 
due to the in vivo selection of progenitor clones with an active normal allele.
14,15
 In order to test 
if clonal selection was present in adult Xpna mice we utilized the X chromosome associated red 
blood cell marker Pgk1. Data from our study found that reticulocytes were present from two 
distinct cell populations in the mice based upon X chromosome inactivation. This suggests that 
clonal selection is not occurring and therefore not responsible for the transitional anemia in Xpna 
mice.  
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 The alternative shorter isoform of GATA-1, GATA-1s, which lacks the N-terminal 
activation domain, was also hypothesized to be a potential mechanism for the transitional 
anemia. Overexpression of GATA-1s in male hemizygous Gata1
ΔN
 mice, which has an in-frame 
deletion of codons for amino acids 3 to 63 in Exon 2 of Gata1, was shown to support normal 
adult megakaryopoiesis, platelet formation, and erythropoiesis with no disturbances to 
hematological parameters or spleen structure.
28
 Expression of GATA-1s at levels comparable 
that were comparable to endogenous GATA-1 expression using the Gata1
ΔNT
 mutant, which has 
a deletion of N-terminal amino acids 1 through 83, was shown to not be sufficient to sustain 
definitive erythropoiesis.
29
 This suggests that GATA-1s is only able to sustain erythropoiesis 
when expression is higher than that of endogenous GATA-1.   
 Exon 1Eb/c containing Gata1 transcripts were shown in adult Gata1
IECKO/Y 
mice to 
predominantly result in the expression of GATA-1s at low levels, due to inefficient translation.
3
 
Additionally, immunohistochemical analysis of the spleens in these mice showed that full-length 
GATA-1 was not detectable, which suggests that Exon 1Eb/c does not have the ability to 
produce full-length GATA-1 protein.
3
  
 The lack of evidence of clonal selection suggests that based off of X chromosome 
inactivation, there are two erythroid lineages present in adult Xpna mice. Our data from the Pgk1 
study suggests that erythroid progenitor cells which have an active X chromosome containing the 
Xpna Gata1 allele are able to produce mature red blood cells despite only expressing the Exon 
1Eb/c form of Gata1 mRNA. When considering the results of the Gata1
IECKO/Y
 study, we 
speculate that these erythroid progenitor cells in Xpna mice are able to produce mature red blood 
cells without the expression of full-length GATA-1 protein. Furthermore, the inefficient 
translation of Exon 1Eb/c containing Gata1 transcripts suggests that erythropoiesis is occurring 
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in the cell lineages with minimal expression of GATA-1s. We hypothesize that erythropoiesis is 
occurring in these cell lineages that only express the Xpna Gata1 allele due to a compensatory 
erythropoietic factor. We speculate that this compensatory mechanism is developmentally 
expressed and is responsible for the recovery from anemia in the neonatal period. We further 
speculate that this compensatory factor does not impact megakaryopoiesis. The spleens in adult 
Xpna had marked megakaryocytosis and elevated levels of Gata2 mRNA. These findings are 
consistent with the results of GATA-2 overexpression in GATA-1s knockin mice, which 
exhibited aberrant megakaryopoiesis.
30
 Further studies of the Xpna mice will be needed will be 
needed to identify compensatory factor.   
Conclusions 
 In conclusion we have characterized the phenotype and genotype of the Xpna mutation.  
Xpna/+ mice are characterized by a transient, neonatal anemia due to splicing mutation of the 
Gata1 gene. The Xpna mouse mutant acts as a model for studying Gata1 alternative first exon 
1Eb/c. The mechanism for recovery from the severe, neonatal anemia is not known, but our 
study suggests that a compensatory erythropoietic factor is the likely mechanism. Further 
research is warranted to identify novel erythropoietic factor.  
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